Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 90 articles:
HTML format
Text format



Single Articles


    May 2018
  1. KOLSTAD KD, Li S, Steen V, Chung L, et al
    Long-term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
    Chest. 2018 May 16. pii: S0012-3692(18)30736-0. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


  2. TANIGUCHI Y, Brenot P, Jais X, Garcia C, et al
    Poor Subpleural Perfusion Predicts Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2018 May 3. pii: S0012-3692(18)30659-7. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    April 2018
  3. MATHAI SC, Mathew S
    Breathing (and Coding?) a Bit Easier: Changes to International Classification of Disease Coding for Pulmonary Hypertension.
    Chest. 2018 Apr 20. pii: S0012-3692(18)30568-3. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    January 2018
  4. NAEIJE R, Saggar R, Badesch D, Rajagopalan S, et al
    Exercise-Induced Pulmonary Hypertension Translating Pathophysiological Concepts into Clinical Practice.
    Chest. 2018 Jan 27. pii: S0012-3692(18)30161-2. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    December 2017
  5. KHOURI C, Lepelley M, Roustit M, Montastruc F, et al
    Comparative safety of drugs targeting the nitric oxide pathway in pulmonary hypertension: a mixed approach combining a meta-analysis of clinical trials and a disproportionality analysis from the WHO pharmacovigilance database.
    Chest. 2017 Dec 21. pii: S0012-3692(17)33265-8. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  6. HILL NS, Gillespie MN, McMurtry IF
    Fifty Years of Monocrotaline-Induced Pulmonary Hypertension: What Has It Meant to the Field?
    Chest. 2017;152:1106-1108.
    PubMed     Text format    


    October 2017
  7. CHADDHA U, Puscas I, Prosper A, Ganesh S, et al
    A 63-Year-Old Woman With Neurofibromatosis Type 1 and Pulmonary Hypertension With Worsening Hypoxemia.
    Chest. 2017;152:e89-e93.
    PubMed     Text format     Abstract available


    August 2017
  8. HACHULLA E, Jais X, Cinquetti G, Clerson P, et al
    Pulmonary arterial hypertension associated with systemic lupus: results from the French Pulmonary Hypertension Registry.
    Chest. 2017 Aug 26. pii: S0012-3692(17)31430-7. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


    July 2017
  9. RAMJUG S, Hussain N, Hurdman J, Billings C, et al
    Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Chest. 2017;152:92-102.
    PubMed     Text format     Abstract available


    June 2017
  10. KAY JM
    Crotalaria (Monocrotaline) Pulmonary Hypertension: The Fiftieth Anniversary.
    Chest. 2017 Jun 19. pii: S0012-3692(17)31082-6. doi: 10.1016/j.chest.2017.
    PubMed     Text format    


  11. HARARI S, Elia D, Humbert M
    Pulmonary hypertension in parenchymal lung diseases: any future for new therapies?
    Chest. 2017 Jun 16. pii: S0012-3692(17)31077-2. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  12. WAXMAN AB, McElderry HT, Gomberg-Maitland M, Burke MC, et al
    Totally Implantable Intravenous Treprostinil Therapy in Pulmonary Hypertension: Assessment of the Implantation Procedure.
    Chest. 2017 Jun 2. pii: S0012-3692(17)31021-8. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


    May 2017
  13. JOSE A, King CS, Shlobin OA, Kiernan JM, et al
    Ventricular diastolic pressure ratio as a marker of treatment response in pulmonary hypertension.
    Chest. 2017 May 17. pii: S0012-3692(17)30929-7. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  14. AVIRAM G, Rozenbaum Z, Ziv-Baran T, Berliner S, et al
    Identification of Pulmonary Hypertension Caused by Left Heart Disease (World Health Organization Group 2) Based on Cardiac Chamber Volumes Derived from Chest CT.
    Chest. 2017 May 12. pii: S0012-3692(17)30917-0. doi: 10.1016/j.chest.2017.
    PubMed     Text format     Abstract available


  15. RAEISI-GIGLOU P, Wang XF, Dakkak W, Bair N, et al
    Effect of Weight on Parenteral Prostacyclin Analogues Dosing in Pulmonary Hypertension.
    Chest. 2017;151:1189-1192.
    PubMed     Text format    


    April 2017
  16. BEST DH, Sumner KL, Smith BP, Damjanovich-Colmenares K, et al
    EIF2AK4 Mutations in Patients Diagnosed With Pulmonary Arterial Hypertension.
    Chest. 2017;151:821-828.
    PubMed     Text format     Abstract available


    March 2017
  17. TAKEI M, Kawakami T, Kataoka M, Kuwahira I, et al
    Elucidating the Ventilation/Perfusion Mismatch and Reduction of Diffusing Capacity for Carbon Monoxide in Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2017;151:725-726.
    PubMed     Text format    


  18. ZHOU Q, Wang D, Liu Y, Yang X, et al
    Solnatide Demonstrates Profound Therapeutic Activity in a Rat Model of Pulmonary Edema Induced by Acute Hypobaric Hypoxia and Exercise.
    Chest. 2017;151:658-667.
    PubMed     Text format     Abstract available


    January 2017
  19. MEHTA S, Sastry BK, Souza R, Torbicki A, et al
    Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial.
    Chest. 2017;151:106-118.
    PubMed     Text format     Abstract available


  20. JAIN S, Khera R, Girotra S, Badesch D, et al
    Comparative Effectiveness of Pharmacologic Interventions for Pulmonary Arterial Hypertension: A Systematic Review and Network Meta-Analysis.
    Chest. 2017;151:90-105.
    PubMed     Text format     Abstract available


    December 2016
  21. ZUCKER MJ
    Point: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? YES.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62632-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


  22. HEMNES AR
    Counterpoint: Should wireless pulmonary artery hemodynamic monitoring be used to monitor patients with pulmonary hypertension? No.
    Chest. 2016 Dec 22. pii: S0012-3692(16)62629-6. doi: 10.1016/j.chest.2016.
    PubMed     Text format    


    November 2016
  23. SAHAY S, Melendres-Groves L, Pawar L, Cajigas HR, et al
    Pulmonary Hypertension Care Center Network Improving care and outcomes in PH.
    Chest. 2016 Nov 3. pii: S0012-3692(16)62331-0. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    October 2016
  24. AKIZUKI M, Serizawa N, Ueno A, Adachi T, et al
    Effect of balloon pulmonary angioplasty on respiratory function in patients with chronic thromboembolic pulmonary hypertension.
    Chest. 2016 Oct 13. pii: S0012-3692(16)60761-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    September 2016
  25. KATAOKA M, Momose Y, Aimi Y, Fukuda K, et al
    Familial Chronic Thromboembolic Pulmonary Hypertension in a Pair of Japanese Brothers.
    Chest. 2016;150:748-9.
    PubMed     Text format    


    August 2016
  26. D'ALTO M, Romeo E, Argiento P, Motoji Y, et al
    Clinical relevance of fluid challenge in patients evaluated for pulmonary hypertension.
    Chest. 2016 Aug 26. pii: S0012-3692(16)57833.
    PubMed     Text format     Abstract available


  27. SHLOBIN OA, Brown AW, Nathan SD
    Pulmonary Hypertension in Diffuse Parenchymal Lung Diseases.
    Chest. 2016 Aug 20. pii: S0012-3692(16)56163-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    July 2016
  28. BOURGE RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, et al
    Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Chest. 2016;150:27-34.
    PubMed     Text format     Abstract available


  29. MATURA LA, Shou H, Fritz JS, Smith KA, et al
    Physical Activity and Symptoms in Pulmonary Arterial Hypertension.
    Chest. 2016;150:46-56.
    PubMed     Text format     Abstract available


    June 2016
  30. GHOFRANI HA, Humbert M, Langleben D, Schermuly R, et al
    Riociguat: Mode of action and clinical development in pulmonary hypertension.
    Chest. 2016 Jun 2. pii: S0012-3692(16)49111-7. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  31. HUERTAS A, Phan C, Bordenave J, Tu L, et al
    Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.
    Chest. 2016;149:1482-93.
    PubMed     Text format     Abstract available


    May 2016
  32. FRITZ JS, Smith KA
    The Pulmonary Hypertension Consult: Clinical and Coding Considerations.
    Chest. 2016 May 14. pii: S0012-3692(16)49006-9. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  33. ROSE JA, Cleveland JM, Rao Y, Minai OA, et al
    Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
    Chest. 2016;149:1234-44.
    PubMed     Text format     Abstract available


  34. MAR PL, Nwazue V, Black BK, Biaggioni I, et al
    Valsalva Maneuver in Pulmonary Arterial Hypertension: Susceptibility to Syncope and Autonomic Dysfunction.
    Chest. 2016;149:1252-60.
    PubMed     Text format     Abstract available


  35. MEHARI A, Klings ES
    Chronic Pulmonary Complications of Sickle Cell Disease.
    Chest. 2016;149:1313-24.
    PubMed     Text format     Abstract available


  36. WELLS JM, Morrison JB, Bhatt SP, Nath H, et al
    Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.
    Chest. 2016;149:1197-204.
    PubMed     Text format     Abstract available


    April 2016
  37. DESMARAIS J, Elliott CG
    Familial Chronic Thromboembolic Pulmonary Hypertension.
    Chest. 2016;149:e99-e101.
    PubMed     Text format     Abstract available


  38. KWON Y, Gomberg-Maitland M, Pritzker M, Thenappan T, et al
    Telangiectasia and Pulmonary Arterial Hypertension Following Treatment With Trastuzumab Emtansine: A Case Report.
    Chest. 2016;149:e103-5.
    PubMed     Text format     Abstract available


  39. REXHAJ E, Rimoldi SF, Pratali L, Brenner R, et al
    Sleep-Disordered Breathing and Vascular Function in Patients With Chronic Mountain Sickness and Healthy High-Altitude Dwellers.
    Chest. 2016;149:991-8.
    PubMed     Text format     Abstract available


    March 2016
  40. ELLIOTT CG
    Use of Parenteral Prostanoids: Important Insights for CHEST Physicians.
    Chest. 2016;149:615-6.
    PubMed     Text format    


  41. RENARD S, Borentain P, Salaun E, Benhaourech S, et al
    Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir.
    Chest. 2016;149:e69-73.
    PubMed     Text format     Abstract available


  42. HAY BR, Pugh ME, Robbins IM, Hemnes AR, et al
    Parenteral Prostanoid Use at a Tertiary Referral Center: A Retrospective Cohort Study.
    Chest. 2016;149:660-6.
    PubMed     Text format     Abstract available


    February 2016
  43. HASLER ED, Muller-Mottet S, Furian M, Saxer S, et al
    Pressure-flow during exercise catheterization predicts survival in pulmonary hypertension.
    Chest. 2016 Feb 15. pii: S0012-3692(16)01253-8. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


  44. AGARWAL R, Gomberg-Maitland M
    Physiologic Markers of Exercise as a Potential Screening Tool for the Detection of Pulmonary Hypertension: "alpha" Few Steps Forward.
    Chest. 2016;149:295-7.
    PubMed     Text format    


  45. LAU EM, Chemla D, Godinas L, Zhu K, et al
    Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease.
    Chest. 2016;149:353-61.
    PubMed     Text format     Abstract available


    January 2016
  46. HOPPER RK, Abman SH, Ivy DD
    Persistent Challenges in Pediatric Pulmonary Hypertension.
    Chest. 2016 Jan 22. pii: S0012-3692(16)00469-4. doi: 10.1016/j.chest.2016.
    PubMed     Text format     Abstract available


    October 2015
  47. GERGES C, Gerges M, Skoro-Sajer N, Zhou Y, et al
    Hemodynamic thresholds for pre-capillary pulmonary hypertension.
    Chest. 2015 Oct 22. doi: 10.1378/chest.15-0928.
    PubMed     Text format     Abstract available


  48. RICHTER SE, Roberts KE, Preston IR, Hill NS, et al
    A simple derived prediction score for the identification of an elevated pulmonary artery wedge pressure using pre-catheterization clinical data in patients referred to a pulmonary hypertension center.
    Chest. 2015 Oct 22. doi: 10.1378/chest.15-0819.
    PubMed     Text format     Abstract available


  49. BONHAM CA, Oldham JM, Gomberg-Maitland M, Vij R, et al
    Prostacyclin and Oral Vasodilator Therapy in Sarcoidosis-Associated Pulmonary Hypertension: A Retrospective Case Series.
    Chest. 2015;148:1055-62.
    PubMed     Text format     Abstract available


  50. HAUTEFORT A, Girerd B, Montani D, Cohen-Kaminsky S, et al
    Response.
    Chest. 2015;148:e132-3.
    PubMed     Text format    


  51. HARBAUM L, Oqueka T, Glatzel A, Hennigs JK, et al
    Does circulating IL-17 identify a subset of patients with idiopathic pulmonary arterial hypertension?
    Chest. 2015;148:e131-2.
    PubMed     Text format    


  52. GAZZANA MB, Knorst MM
    Therapy for pulmonary arterial hypertension: approved dosages should be prescribed in clinical practice.
    Chest. 2015;148:e126.
    PubMed     Text format    


  53. FARBER HW, Miller DP, Poms AD, Badesch DB, et al
    Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Chest. 2015;148:1043-54.
    PubMed     Text format     Abstract available


    September 2015
  54. IVY DD, Abman S
    Beyond the 6-Minute Walk Test for Assessing Pediatric Pulmonary Hypertension: Making Strides Through Combination End Points.
    Chest. 2015;148:576-7.
    PubMed     Text format    


  55. PLOEGSTRA MJ, Arjaans S, Zijlstra WM, Douwes JM, et al
    Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
    Chest. 2015;148:655-66.
    PubMed     Text format     Abstract available


    July 2015
  56. LYLE MA, Fenstad ER, McGoon MD, Frantz RP, et al
    Pulmonary Hypertension in the setting of Hereditary Hemorrhagic Telangiectasia.
    Chest. 2015 Jul 23. doi: 10.1378/chest.15-0535.
    PubMed     Text format     Abstract available


    June 2015
  57. HAUTEFORT A, Girerd B, Montani D, Cohen-Kaminsky S, et al
    T-helper 17 cell polarization in pulmonary arterial hypertension.
    Chest. 2015;147:1610-20.
    PubMed     Text format     Abstract available


    May 2015
  58. GIRERD B, Coulet F, Jais X, Eyries M, et al
    Characteristics of pulmonary arterial hypertension in affected carriers of a mutation located in the cytoplasmic tail of bone morphogenetic protein receptor type 2.
    Chest. 2015;147:1385-94.
    PubMed     Text format     Abstract available


    April 2015
  59. CHEMLA D, Humbert M, Sitbon O, Montani D, et al
    Systolic and mean pulmonary artery pressures: are they interchangeable in patients with pulmonary hypertension?
    Chest. 2015;147:943-50.
    PubMed     Text format     Abstract available


  60. TAN GM, Tay EL, Tai BC, Yip JW, et al
    Idiopathic pulmonary arterial hypertension in Asians: a long-term study on clinical outcomes.
    Chest. 2015;147:e160-3.
    PubMed     Text format    


  61. VAN DE VEERDONK MC, Marcus JT, Westerhof N, de Man FS, et al
    Signs of right ventricular deterioration in clinically stable patients with pulmonary arterial hypertension.
    Chest. 2015;147:1063-71.
    PubMed     Text format     Abstract available


  62. NEWMAN JH, Brittain EL, Robbins IM, Hemnes AR, et al
    Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension.
    Chest. 2015;147:1080-5.
    PubMed     Text format     Abstract available


    March 2015
  63. SCHLOSSER K, Taha M, Deng Y, Jiang B, et al
    Discordant regulation of microRNA between multiple experimental models and human pulmonary hypertension.
    Chest. 2015 Mar 12. doi: 10.1378/chest.14-2169.
    PubMed     Text format     Abstract available


  64. ISMAIL K, Roberts K, Manning P, Manley C, et al
    OSA and Pulmonary Hypertension: Time for a New Look.
    Chest. 2015;147:847-61.
    PubMed     Text format     Abstract available


    February 2015
  65. GUIGNABERT C, Tu L, Girerd B, Ricard N, et al
    New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.
    Chest. 2015;147:529-37.
    PubMed     Text format     Abstract available


  66. FRANTZ RP, Schilz RJ, Chakinala MM, Badesch DB, et al
    Hospitalization and survival in patients using epoprostenol for injection in the PROSPECT observational study.
    Chest. 2015;147:484-94.
    PubMed     Text format     Abstract available


  67. ALVES JL JR, Gavilanes F, Jardim C, Fernandes CJ, et al
    Pulmonary arterial hypertension in the southern hemisphere: results from a registry of incident Brazilian cases.
    Chest. 2015;147:495-501.
    PubMed     Text format     Abstract available


  68. MIRSAEIDI M, Machado RF, Schraufnagel D, Sweiss NJ, et al
    Racial difference in sarcoidosis mortality in the United States.
    Chest. 2015;147:438-49.
    PubMed     Text format     Abstract available


    January 2015
  69. GUAZZI M, Naeije R, Arena R, Corra U, et al
    Echocardiography of Right Ventriculo-Arterial Coupling Combined to Cardiopulmonary Exercise Testing to Predict Outcome in Heart Failure.
    Chest. 2015 Jan 29. doi: 10.1378/chest.14-2065.
    PubMed     Text format     Abstract available


  70. AUSTIN C, Alassas K, Burger C, Safford R, et al
    Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension.
    Chest. 2015;147:198-208.
    PubMed     Text format     Abstract available


  71. MATHAI SC, Hassoun PM, Puhan MA, Zhou Y, et al
    Sex differences in response to tadalafil in pulmonary arterial hypertension.
    Chest. 2015;147:188-97.
    PubMed     Text format     Abstract available


    December 2014
  72. KOVACS G, Avian A, Tscherner M, Foris V, et al
    Characterization of patients with borderline pulmonary arterial pressure.
    Chest. 2014;146:1486-93.
    PubMed     Text format     Abstract available


  73. CHUNG L, Farber HW, Benza R, Miller DP, et al
    Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry.
    Chest. 2014;146:1494-504.
    PubMed     Text format     Abstract available


  74. BRITTAIN EL, Janz DR, Austin ED, Bastarache JA, et al
    Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension.
    Chest. 2014;146:1478-85.
    PubMed     Text format     Abstract available


    November 2014
  75. BRENNER R, Pratali L, Rimoldi SF, Murillo Jauregui CX, et al
    Exaggerated pulmonary hypertension and right ventricular dysfunction in high-altitude dwellers with patent foramen ovale.
    Chest. 2014 Nov 6. doi: 10.1378/chest.14-1353.
    PubMed     Text format     Abstract available


  76. BURGER CD, Long PK, Shah MR, McGoon MD, et al
    Characterization of first-time hospitalizations in patients with newly diagnosed pulmonary arterial hypertension in the REVEAL registry.
    Chest. 2014;146:1263-73.
    PubMed     Text format     Abstract available


    October 2014
  77. RUDSKI LG, Bossone E, Langleben D
    From the echo bed to the pulmonary vascular bed: dobutamine testing in the noninvasive laboratory.
    Chest. 2014;146:876-8.
    PubMed     Text format    


  78. LAU EM, Vanderpool RR, Choudhary P, Simmons LR, et al
    Dobutamine stress echocardiography for the assessment of pressure-flow relationships of the pulmonary circulation.
    Chest. 2014;146:959-66.
    PubMed     Text format     Abstract available


    September 2014
  79. AL-NAAMANI N, Roberts KE, Hill NS, Preston IR, et al
    Imatinib as rescue therapy in a patient with pulmonary hypertension associated with Gaucher disease.
    Chest. 2014;146:e81-3.
    PubMed     Text format     Abstract available


  80. RIVAL G, Lacasse Y, Martin S, Bonnet S, et al
    Effect of pulmonary arterial hypertension-specific therapies on health-related quality of life: a systematic review.
    Chest. 2014;146:686-708.
    PubMed     Text format     Abstract available


    August 2014
  81. HEMNES AR
    Pulmonary arterial hypertension treatment guidelines: new answers and even more questions.
    Chest. 2014;146:239-41.
    PubMed     Text format    


  82. TAICHMAN DB, Ornelas J, Chung L, Klinger JR, et al
    Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report.
    Chest. 2014;146:449-75.
    PubMed     Text format     Abstract available


    July 2014
  83. SCHUMACHER DS, Muller-Mottet S, Hasler ED, Hildenbrand FF, et al
    Effect of oxygen and acetazolamide on nocturnal cardiac conduction, repolarization and arrhythmias in pre-capillary pulmonary hypertension and sleep-disturbed breathing.
    Chest. 2014 Jul 3. doi: 10.1378/chest.14-0495.
    PubMed     Text format     Abstract available


  84. BONDERMAN D, Pretsch I, Steringer-Mascherbauer R, Jansa P, et al
    Acute Hemodynamic Effects of Riociguat in Patients with Pulmonary Hypertension Associated with Diastolic Heart Failure (DILATE-1): A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study.
    Chest. 2014 Jul 3. doi: 10.1378/chest.14-0106.
    PubMed     Text format     Abstract available


    June 2014
  85. GNANAVEL S, Robert RS
    Quality of life and parental adjustment in pediatric pulmonary hypertension: some methodologic considerations.
    Chest. 2014;145:1439.
    PubMed     Text format    


  86. MULLEN MP, DeMaso DR
    Response.
    Chest. 2014;145:1439.
    PubMed     Text format    


  87. WIENER RS, Ouellette DR, Diamond E, Fan VS, et al
    An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine.
    Chest. 2014;145:1383-91.
    PubMed     Text format     Abstract available


  88. HATTON N, Ryan JJ
    Sex differences in response to pulmonary arterial hypertension therapy: is what's good for the goose, good for the gander?
    Chest. 2014;145:1184-6.
    PubMed     Text format    


  89. JACOBS W, van de Veerdonk MC, Trip P, de Man F, et al
    The right ventricle explains sex differences in survival in idiopathic pulmonary arterial hypertension.
    Chest. 2014;145:1230-6.
    PubMed     Text format     Abstract available


    May 2014
  90. COEYTAUX RR, Schmit KM, Kraft BD, Kosinski AS, et al
    Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta-analysis.
    Chest. 2014;145:1055-63.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: